Time-dependent pharmacokinetics describes clearance or bioavailability changes with repeated dosing. Enzyme induction from repeat dosing increases metabolism reducing bioavailability. Enzyme inhibition from metabolite accumulation decreases metabolism increasing bioavailability. Saturation effects change kinetics at higher concentrations. Reversibility assessment determines permanence of changes.
Population pharmacokinetics identify time-dependent parameters. Regulatory submissions address time-dependent kinetics. Clinical monitoring detects bioavailability changes. Dose adjustments account for time-dependency. Post-approval monitoring confirms predictions.
Pharmacokinetics & Pharmacodynamics (PK/PD)
Time-Dependent Pharmacokinetics
Time-dependent pharmacokinetics describes changes in pharmacokinetic behaviour over time caused by factors such as enzyme induction, inhibition or physiological adaptation.
Continue Exploring
Browse over 900 biopharmaceutical terms across biologics, ADCs, cell & gene therapy, CMC, clinical development and manufacturing.
Browse Glossary →